Pilot production of new polypropylene products at Luoyang Petrochemical
On September 9, Sinopec produced PPH-YJ40X, a special polypropylene resin for antibacterial and low odor spunbond nonwovens, for the first time.
Since the outbreak of the Xinguan epidemic, Sinopec has proposed to further enhance the production capacity of high-end medical raw materials and dressings around the epidemic. The Y35X produced by Luoyang Petrochemical is used for medical masks and surgical gowns, which has made a due contribution to the fight against the epidemic, but the product cannot be used in antibacterial and anti-virus medical fields.
However, the product cannot be used in medical fields such as antibacterial and anti-viral applications. In order to enhance the strength in fighting epidemics and increase the efficiency of the company, Loyang Petrochemical Company and Beihang Chemical Institute jointly developed PPH-YJ40X, a special polypropylene resin for spunbond nonwoven fabrics with antibacterial and low odor.
On September 9, the company's 2# polypropylene unit was scaled up for industrial production, with the focus on the operational stability of the pelletizing machine.
2026-10-03
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Polypropylene vs Polycarbonate: What Is the Difference?
-
Global polypropylene supply and demand variables increase steeply
-
2021 half year summary:Olefin and Alcohols
-
Study:Polypropylene bottles may release plastic particles when flushed with milk
-
Middle East Capital Moves In: SABIC Plans RMB 33 Billion Stake in Rongsheng Petrochemical
-
Akzo Nobel and Axalta Announce a $25 Billion Merger Deal
-
Clariant and FUHUA Establish Joint Venture to Co-Develop Halogen-Free Flame Retardants
-
Multiple Chemical Industry Leaders Post Strong H1 Earnings Growth as Sector Profitability Revives
-
Dow Chemical Weighs Exit from $20 Billion Chemical Joint Venture with Saudi Aramco
-
CordenPharma Invests €80 Million to Raise Sterile Injectable Capacity to 500 Million Units Annually
Recommend Reading
-
ZPC Plans 1.2 Million-Tonne PDH Unit, Setting a New Global Licensing Record
-
Eurofragance Launches Proprietary Fragrance Ingredient Olivante
-
BASF Raises Acid Chloride and Chloroformate Capacity by 30% at Ludwigshafen
-
Huntsman Partners with Wobatek to Expand TPU Distribution
-
BASF Sues Apple Over Face Authentication Patents Used in Dozens of iPhones and iPads
-
Production Slows Sharply, But Isooctanol Prices Surge This Week
-
This Week's Caustic Soda Price Consolidation Trend (7.13-7.17) in China
-
Business Society’s Market Outlook for Hydrofluoric Acid on September 9, 2026: Volatile
-
This Week, China's Titanium Dioxide Market Trended Downward (11.3-11.7)
-
This Week's Pure Benzene Market Prices Rose in China (7.13-7.17)